Low-Dose Buprenorphine Initiation for Opioid Agonist Therapy in Patients with Opioid Use Disorder: A Dutch Consensus Paper
Though various protocols for LDBI exist, physicians experienced with LDBI agreed on the range of safe LDBI regimens. Further research is necessary to develop comprehensive guidelines for LDBI in patients with opioid use disorder.
Authors
- Arnt Schellekens (ORCID: https://orcid.org/0000-0002-7715-5209)
- Niki Lijftogt (ORCID: https://orcid.org/0000-0003-3250-2374)
- Thomas Knuijver (ORCID: https://orcid.org/0000-0002-9729-1283)
- Boukje A.G. Dijkstra (ORCID: https://orcid.org/0000-0003-1467-7808)
- Stijn E. Veldman
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- IrisZorg (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- Nijmegen Institute for Scientist Practitioners in Addiction (NL)
- Jellinek (NL)
- Novay (NL)
Publication Details
- Journal
- European Addiction Research
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1159/000549129
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00